nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—cerebellar cortex—brain cancer	0.108	0.17	CbGeAlD
Mepivacaine—SCN8A—hindbrain—brain cancer	0.0296	0.0467	CbGeAlD
Mepivacaine—SCN10A—ganglion—brain cancer	0.0261	0.0412	CbGeAlD
Mepivacaine—SCN1A—hindbrain—brain cancer	0.0224	0.0353	CbGeAlD
Mepivacaine—SCN2A—hindbrain—brain cancer	0.0205	0.0324	CbGeAlD
Mepivacaine—Meningitis—Carmustine—brain cancer	0.0172	0.0493	CcSEcCtD
Mepivacaine—SCN8A—brainstem—brain cancer	0.0169	0.0268	CbGeAlD
Mepivacaine—SCN8A—telencephalon—brain cancer	0.015	0.0237	CbGeAlD
Mepivacaine—SCN1A—brainstem—brain cancer	0.0128	0.0202	CbGeAlD
Mepivacaine—SCN2A—brainstem—brain cancer	0.0118	0.0186	CbGeAlD
Mepivacaine—SCN1A—telencephalon—brain cancer	0.0114	0.018	CbGeAlD
Mepivacaine—SCN9A—pituitary gland—brain cancer	0.0108	0.017	CbGeAlD
Mepivacaine—SCN8A—spinal cord—brain cancer	0.0105	0.0166	CbGeAlD
Mepivacaine—SCN2A—telencephalon—brain cancer	0.0104	0.0165	CbGeAlD
Mepivacaine—SCN10A—telencephalon—brain cancer	0.0101	0.0159	CbGeAlD
Mepivacaine—SCN4A—pituitary gland—brain cancer	0.0096	0.0152	CbGeAlD
Mepivacaine—SCN9A—midbrain—brain cancer	0.00949	0.015	CbGeAlD
Mepivacaine—SCN8A—endocrine gland—brain cancer	0.00949	0.015	CbGeAlD
Mepivacaine—SCN8A—head—brain cancer	0.00937	0.0148	CbGeAlD
Mepivacaine—SCN9A—spinal cord—brain cancer	0.00926	0.0146	CbGeAlD
Mepivacaine—Lidocaine—EGFR—brain cancer	0.00921	0.523	CrCbGaD
Mepivacaine—SCN3A—telencephalon—brain cancer	0.00917	0.0145	CbGeAlD
Mepivacaine—SCN1A—medulla oblongata—brain cancer	0.00893	0.0141	CbGeAlD
Mepivacaine—SCN8A—central nervous system—brain cancer	0.00855	0.0135	CbGeAlD
Mepivacaine—SCN2A—pituitary gland—brain cancer	0.0085	0.0134	CbGeAlD
Mepivacaine—Lidocaine—CYP2C9—brain cancer	0.0084	0.477	CrCbGaD
Mepivacaine—SCN8A—cerebellum—brain cancer	0.00836	0.0132	CbGeAlD
Mepivacaine—SCN2A—medulla oblongata—brain cancer	0.0082	0.0129	CbGeAlD
Mepivacaine—SCN10A—pituitary gland—brain cancer	0.00819	0.0129	CbGeAlD
Mepivacaine—SCN1A—midbrain—brain cancer	0.00817	0.0129	CbGeAlD
Mepivacaine—SCN1A—spinal cord—brain cancer	0.00797	0.0126	CbGeAlD
Mepivacaine—SCN2A—midbrain—brain cancer	0.00749	0.0118	CbGeAlD
Mepivacaine—SCN3A—pituitary gland—brain cancer	0.00747	0.0118	CbGeAlD
Mepivacaine—SCN4A—head—brain cancer	0.00734	0.0116	CbGeAlD
Mepivacaine—SCN2A—spinal cord—brain cancer	0.00731	0.0115	CbGeAlD
Mepivacaine—SCN3A—medulla oblongata—brain cancer	0.00721	0.0114	CbGeAlD
Mepivacaine—SCN1A—head—brain cancer	0.00708	0.0112	CbGeAlD
Mepivacaine—SCN10A—spinal cord—brain cancer	0.00705	0.0111	CbGeAlD
Mepivacaine—SCN8A—brain—brain cancer	0.00679	0.0107	CbGeAlD
Mepivacaine—SCN4A—central nervous system—brain cancer	0.0067	0.0106	CbGeAlD
Mepivacaine—SCN3A—midbrain—brain cancer	0.00659	0.0104	CbGeAlD
Mepivacaine—SCN2A—endocrine gland—brain cancer	0.00658	0.0104	CbGeAlD
Mepivacaine—Sweating increased—Procarbazine—brain cancer	0.00652	0.0187	CcSEcCtD
Mepivacaine—SCN2A—head—brain cancer	0.0065	0.0103	CbGeAlD
Mepivacaine—SCN1A—central nervous system—brain cancer	0.00646	0.0102	CbGeAlD
Mepivacaine—Urinary incontinence—Carmustine—brain cancer	0.00644	0.0185	CcSEcCtD
Mepivacaine—SCN3A—spinal cord—brain cancer	0.00643	0.0101	CbGeAlD
Mepivacaine—SCN10A—endocrine gland—brain cancer	0.00635	0.01	CbGeAlD
Mepivacaine—SCN1A—cerebellum—brain cancer	0.00632	0.00997	CbGeAlD
Mepivacaine—SCN10A—head—brain cancer	0.00627	0.00989	CbGeAlD
Mepivacaine—Urinary incontinence—Temozolomide—brain cancer	0.00622	0.0178	CcSEcCtD
Mepivacaine—Apnoea—Etoposide—brain cancer	0.00608	0.0174	CcSEcCtD
Mepivacaine—SCN9A—brain—brain cancer	0.00596	0.00942	CbGeAlD
Mepivacaine—Drowsiness—Procarbazine—brain cancer	0.00596	0.0171	CcSEcCtD
Mepivacaine—SCN2A—central nervous system—brain cancer	0.00593	0.00937	CbGeAlD
Mepivacaine—SCN2A—cerebellum—brain cancer	0.0058	0.00915	CbGeAlD
Mepivacaine—SCN10A—central nervous system—brain cancer	0.00572	0.00903	CbGeAlD
Mepivacaine—Sweating—Procarbazine—brain cancer	0.00572	0.0164	CcSEcCtD
Mepivacaine—SCN3A—head—brain cancer	0.00571	0.00902	CbGeAlD
Mepivacaine—SCN5A—head—brain cancer	0.00569	0.00899	CbGeAlD
Mepivacaine—Swelling—Carmustine—brain cancer	0.00549	0.0157	CcSEcCtD
Mepivacaine—Body temperature increased—Carboplatin—brain cancer	0.00541	0.0155	CcSEcCtD
Mepivacaine—SCN4A—brain—brain cancer	0.00532	0.0084	CbGeAlD
Mepivacaine—SCN3A—central nervous system—brain cancer	0.00521	0.00823	CbGeAlD
Mepivacaine—SCN5A—central nervous system—brain cancer	0.0052	0.00821	CbGeAlD
Mepivacaine—SCN1A—brain—brain cancer	0.00513	0.0081	CbGeAlD
Mepivacaine—SCN3A—cerebellum—brain cancer	0.0051	0.00804	CbGeAlD
Mepivacaine—Chills—Procarbazine—brain cancer	0.0048	0.0138	CcSEcCtD
Mepivacaine—Body temperature increased—Lomustine—brain cancer	0.00474	0.0136	CcSEcCtD
Mepivacaine—SCN2A—brain—brain cancer	0.00471	0.00744	CbGeAlD
Mepivacaine—Drowsiness—Hydroxyurea—brain cancer	0.00462	0.0132	CcSEcCtD
Mepivacaine—Tension—Procarbazine—brain cancer	0.00457	0.0131	CcSEcCtD
Mepivacaine—SCN10A—brain—brain cancer	0.00454	0.00717	CbGeAlD
Mepivacaine—Nervousness—Procarbazine—brain cancer	0.00453	0.013	CcSEcCtD
Mepivacaine—Tremor—Procarbazine—brain cancer	0.00437	0.0125	CcSEcCtD
Mepivacaine—Swelling—Etoposide—brain cancer	0.00424	0.0122	CcSEcCtD
Mepivacaine—Syncope—Procarbazine—brain cancer	0.00418	0.012	CcSEcCtD
Mepivacaine—SCN3A—brain—brain cancer	0.00414	0.00653	CbGeAlD
Mepivacaine—SCN5A—brain—brain cancer	0.00413	0.00652	CbGeAlD
Mepivacaine—Loss of consciousness—Procarbazine—brain cancer	0.0041	0.0117	CcSEcCtD
Mepivacaine—Convulsion—Procarbazine—brain cancer	0.00404	0.0116	CcSEcCtD
Mepivacaine—Hypertension—Procarbazine—brain cancer	0.00402	0.0115	CcSEcCtD
Mepivacaine—Anxiety—Procarbazine—brain cancer	0.00395	0.0113	CcSEcCtD
Mepivacaine—Sweating increased—Temozolomide—brain cancer	0.00394	0.0113	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Etoposide—brain cancer	0.00387	0.0111	CcSEcCtD
Mepivacaine—Vomiting—Lomustine—brain cancer	0.00381	0.0109	CcSEcCtD
Mepivacaine—Oedema—Procarbazine—brain cancer	0.0038	0.0109	CcSEcCtD
Mepivacaine—Shock—Procarbazine—brain cancer	0.00374	0.0107	CcSEcCtD
Mepivacaine—Chills—Hydroxyurea—brain cancer	0.00372	0.0107	CcSEcCtD
Mepivacaine—Tachycardia—Procarbazine—brain cancer	0.00371	0.0106	CcSEcCtD
Mepivacaine—Hyperhidrosis—Procarbazine—brain cancer	0.00368	0.0105	CcSEcCtD
Mepivacaine—Erythema—Hydroxyurea—brain cancer	0.00361	0.0103	CcSEcCtD
Mepivacaine—Cardiac arrest—Etoposide—brain cancer	0.00356	0.0102	CcSEcCtD
Mepivacaine—Nausea—Lomustine—brain cancer	0.00356	0.0102	CcSEcCtD
Mepivacaine—Hypotension—Procarbazine—brain cancer	0.00355	0.0102	CcSEcCtD
Mepivacaine—Paraesthesia—Procarbazine—brain cancer	0.00342	0.00978	CcSEcCtD
Mepivacaine—Somnolence—Procarbazine—brain cancer	0.00338	0.00969	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—brain cancer	0.00315	0.00903	CcSEcCtD
Mepivacaine—Convulsion—Hydroxyurea—brain cancer	0.00312	0.00895	CcSEcCtD
Mepivacaine—Urticaria—Procarbazine—brain cancer	0.00302	0.00866	CcSEcCtD
Mepivacaine—Tinnitus—Temozolomide—brain cancer	0.00302	0.00865	CcSEcCtD
Mepivacaine—Body temperature increased—Procarbazine—brain cancer	0.00301	0.00861	CcSEcCtD
Mepivacaine—Oedema—Hydroxyurea—brain cancer	0.00294	0.00843	CcSEcCtD
Mepivacaine—Erythema—Carmustine—brain cancer	0.00292	0.00835	CcSEcCtD
Mepivacaine—Chills—Temozolomide—brain cancer	0.0029	0.00832	CcSEcCtD
Mepivacaine—Back pain—Carmustine—brain cancer	0.00282	0.00808	CcSEcCtD
Mepivacaine—Erythema—Temozolomide—brain cancer	0.00282	0.00807	CcSEcCtD
Mepivacaine—Hypersensitivity—Procarbazine—brain cancer	0.0028	0.00803	CcSEcCtD
Mepivacaine—Vision blurred—Carmustine—brain cancer	0.00275	0.00787	CcSEcCtD
Mepivacaine—Tremor—Carmustine—brain cancer	0.00273	0.00783	CcSEcCtD
Mepivacaine—Asthenia—Procarbazine—brain cancer	0.00273	0.00782	CcSEcCtD
Mepivacaine—Back pain—Temozolomide—brain cancer	0.00273	0.00781	CcSEcCtD
Mepivacaine—Pruritus—Procarbazine—brain cancer	0.00269	0.00771	CcSEcCtD
Mepivacaine—Agitation—Carmustine—brain cancer	0.00268	0.00768	CcSEcCtD
Mepivacaine—Vision blurred—Temozolomide—brain cancer	0.00266	0.00761	CcSEcCtD
Mepivacaine—Tremor—Temozolomide—brain cancer	0.00264	0.00756	CcSEcCtD
Mepivacaine—Somnolence—Hydroxyurea—brain cancer	0.00262	0.0075	CcSEcCtD
Mepivacaine—Agitation—Temozolomide—brain cancer	0.00259	0.00742	CcSEcCtD
Mepivacaine—Angioedema—Temozolomide—brain cancer	0.00257	0.00738	CcSEcCtD
Mepivacaine—Convulsion—Carmustine—brain cancer	0.00253	0.00724	CcSEcCtD
Mepivacaine—Hypertension—Carmustine—brain cancer	0.00252	0.00721	CcSEcCtD
Mepivacaine—Dizziness—Procarbazine—brain cancer	0.00252	0.00721	CcSEcCtD
Mepivacaine—Anxiety—Carmustine—brain cancer	0.00247	0.00709	CcSEcCtD
Mepivacaine—Convulsion—Temozolomide—brain cancer	0.00244	0.00699	CcSEcCtD
Mepivacaine—Hypertension—Temozolomide—brain cancer	0.00243	0.00697	CcSEcCtD
Mepivacaine—Vomiting—Procarbazine—brain cancer	0.00242	0.00693	CcSEcCtD
Mepivacaine—Anxiety—Temozolomide—brain cancer	0.00239	0.00685	CcSEcCtD
Mepivacaine—Headache—Procarbazine—brain cancer	0.00238	0.00683	CcSEcCtD
Mepivacaine—Oedema—Carmustine—brain cancer	0.00238	0.00682	CcSEcCtD
Mepivacaine—Body temperature increased—Hydroxyurea—brain cancer	0.00233	0.00667	CcSEcCtD
Mepivacaine—Chills—Etoposide—brain cancer	0.00232	0.00666	CcSEcCtD
Mepivacaine—Tachycardia—Carmustine—brain cancer	0.00232	0.00665	CcSEcCtD
Mepivacaine—Anaphylactic shock—Temozolomide—brain cancer	0.0023	0.00659	CcSEcCtD
Mepivacaine—Oedema—Temozolomide—brain cancer	0.0023	0.00659	CcSEcCtD
Mepivacaine—Nausea—Procarbazine—brain cancer	0.00226	0.00647	CcSEcCtD
Mepivacaine—Hypotension—Carmustine—brain cancer	0.00222	0.00637	CcSEcCtD
Mepivacaine—Hyperhidrosis—Temozolomide—brain cancer	0.00222	0.00637	CcSEcCtD
Mepivacaine—Back pain—Etoposide—brain cancer	0.00218	0.00625	CcSEcCtD
Mepivacaine—Hypersensitivity—Hydroxyurea—brain cancer	0.00217	0.00621	CcSEcCtD
Mepivacaine—Paraesthesia—Carmustine—brain cancer	0.00214	0.00612	CcSEcCtD
Mepivacaine—Somnolence—Carmustine—brain cancer	0.00212	0.00606	CcSEcCtD
Mepivacaine—Asthenia—Hydroxyurea—brain cancer	0.00211	0.00605	CcSEcCtD
Mepivacaine—Paraesthesia—Temozolomide—brain cancer	0.00206	0.00592	CcSEcCtD
Mepivacaine—Somnolence—Temozolomide—brain cancer	0.00204	0.00586	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—brain cancer	0.00198	0.00568	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—brain cancer	0.00195	0.0056	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—brain cancer	0.00195	0.00558	CcSEcCtD
Mepivacaine—Dizziness—Hydroxyurea—brain cancer	0.00195	0.00558	CcSEcCtD
Mepivacaine—Body temperature increased—Carmustine—brain cancer	0.00188	0.00539	CcSEcCtD
Mepivacaine—Vomiting—Hydroxyurea—brain cancer	0.00187	0.00536	CcSEcCtD
Mepivacaine—Headache—Hydroxyurea—brain cancer	0.00184	0.00528	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—brain cancer	0.00184	0.00527	CcSEcCtD
Mepivacaine—Urticaria—Temozolomide—brain cancer	0.00183	0.00523	CcSEcCtD
Mepivacaine—Body temperature increased—Temozolomide—brain cancer	0.00182	0.00521	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—brain cancer	0.0018	0.00515	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—brain cancer	0.00178	0.0051	CcSEcCtD
Mepivacaine—Hypersensitivity—Carmustine—brain cancer	0.00175	0.00502	CcSEcCtD
Mepivacaine—Nausea—Hydroxyurea—brain cancer	0.00175	0.00501	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—brain cancer	0.00172	0.00493	CcSEcCtD
Mepivacaine—Asthenia—Carmustine—brain cancer	0.00171	0.00489	CcSEcCtD
Mepivacaine—Hypersensitivity—Temozolomide—brain cancer	0.00169	0.00485	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—brain cancer	0.00165	0.00473	CcSEcCtD
Mepivacaine—Asthenia—Temozolomide—brain cancer	0.00165	0.00473	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—brain cancer	0.00164	0.00469	CcSEcCtD
Mepivacaine—Pruritus—Temozolomide—brain cancer	0.00163	0.00466	CcSEcCtD
Mepivacaine—Dizziness—Carmustine—brain cancer	0.00157	0.00451	CcSEcCtD
Mepivacaine—Dizziness—Temozolomide—brain cancer	0.00152	0.00436	CcSEcCtD
Mepivacaine—Vomiting—Carmustine—brain cancer	0.00151	0.00433	CcSEcCtD
Mepivacaine—Headache—Carmustine—brain cancer	0.00149	0.00427	CcSEcCtD
Mepivacaine—Vomiting—Temozolomide—brain cancer	0.00146	0.00419	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—brain cancer	0.00146	0.00419	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—brain cancer	0.00145	0.00417	CcSEcCtD
Mepivacaine—Headache—Temozolomide—brain cancer	0.00144	0.00413	CcSEcCtD
Mepivacaine—Nausea—Carmustine—brain cancer	0.00141	0.00405	CcSEcCtD
Mepivacaine—Nausea—Temozolomide—brain cancer	0.00137	0.00391	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—brain cancer	0.00136	0.00388	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—brain cancer	0.00132	0.00378	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—brain cancer	0.0013	0.00373	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—brain cancer	0.00122	0.00349	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—brain cancer	0.00117	0.00335	CcSEcCtD
Mepivacaine—Headache—Etoposide—brain cancer	0.00115	0.0033	CcSEcCtD
Mepivacaine—Nausea—Etoposide—brain cancer	0.00109	0.00313	CcSEcCtD
